Steven Cohen

Last Update: 11-19-2015

Number of Stocks: 751
Number of New Stocks: 258

Total Value: $12,739 Mil
Q/Q Turnover: 43%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Steven Cohen Watch

  • Air Liquide Set to Buy Airgas

    Recently Airgas Inc. (ARG) agreed to be acquired by Air Liquide (AIQUF).

    Air Liquide expects the deal to be active from the next year and plans to realize more than $300 million in pre-tax cost, efficiency and volume synergies.


  • Steven Cohen Is Betting on Oprah's Stake in Weight Watchers

    Steven Cohen (Trades, Portfolio) has acquired 3.79 million shares of Weight Watchers (NYSE:WTW) at an average price of $16.93. His position looks to be inspired by Oprah Winfrey, who became a shareholder, board member and endorser of the company. She bought 10% of the company and has options that bring her stake up another 5%. Before Winfrey arrived on the scene, Cohen did not own shares. His current stake represents about a ~5% stake in the equity.

    Weight Watchers has been on an absolute tear since Winfrey joined and its price was below $7 a share. Since Friday at the close, it is now nearly $23. Although it is unlikely that Cohen will send shares surging like Winfrey did, the guru and founder of SAC Capital and of Point72 Capital was once called the Hedge Fund King in a 2006 Wall Street Journal article, and Bloomberg included him within the 50 most influential ranking in the Bloomberg Markets Magazine as recently as 2011. Weight Watchers has been a very popular short among hedge funds, but that could change rapidly. A star investor betting long against you can be very uncomfortable as Ackman* will tell you.


  • Steven Cohen Adds to Stake in Alder BioPharmaceuticals

    Steven Cohen (Trades, Portfolio) of Point72 Asset Management increased his stake in Alder BioPharmaceuticals Inc. (NASDAQ:ALDR), a Bothell, Wash.-based biopharmaceutical company emphasizing the development of therapies for migraines, autoimmune diseases and inflammatory diseases, by nearly 180% with the purchase of 1,459,556 shares on Oct. 21.

    Cohen paid $28.14 per share in a deal that had a 0.28% impact on his portfolio. The purchase increased Cohen’s stake in the company to 2,278,956 shares.


  • Steven Cohen's Point72 Raises Stake in Spectranetics

    Steven Cohen (Trades, Portfolio)’s hedge fund Point72 Asset Management increased an existing stake in The Spectranetics Corp. (NASDAQ:SPNC), a Colorado Springs, Colo.-based manufacturer of single-use medical devices for minimally invasive cardiovascular procedures, by more than 1,000% on Oct. 8.

    Cohen’s Point72 purchased 2,027,347 shares for an average price of $10.91 per share. The acquisition increased Cohen’s position to 2,214,647 shares – an increase of 1,082.14% – and had a 0.15% impact on Cohen’s portfolio.


  • Insiders Are Selling Dave & Buster's Entertainment and Buying Twinlab

    The All-In-One Guru Screener can be used to find insider buys and sales over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying/All Insider Selling to “$1,000,000+” and duration to "October 2015."

    According to the above filters, the following are the recent buys from company insiders in the past week.


  • Benefiting From a Transition Company After Activist Investor Nelson Peltz's Big Bet

    General Electric Company (NYSE:GE), a $270.79 billion market cap company, sells products ranging from jet engines and gas turbines to consumer appliances, railroad locomotives and medical equipment.

    A $2.5 billion stake


  • Cohen Ups Stake in Olin After Company Announces Merger With Dow Chemical Segments

    Steven Cohen (Trades, Portfolio) of Point72 Asset Management increased his stake in Olin Corp. (NYSE:OLN) on Sept. 18 by about 22%, three days after the company's shareholders approved a merger with certain business segments of Dow Chemical Co. (NYSE:DOW).

    Cohen purchased 894,539 shares for $18.05 per share, bringing his stake to a total of 4,912,822 shares. He now owns 6.34% of the company. The graph below shows Cohen’s holding history in the company.


  • Steve Cohen Increases His Position in Canadian Pacific

    Point72 Asset Management L.P. is a family office managing the assets of its founder, Steven Cohen (Trades, Portfolio), and eligible employees. He is a billionaire hedge fund investor and the founder of SAC Capital Advisors. Cohen grew up in Great Neck, N.Y., and he attended the Wharton School of Business at the University of Pennsylvania.

    Last quarter, the firm increased its position in Canadian Pacific (NYSE:CP) by buying 115,800 shares. As of June 30, he was holding 425,000 shares of the company.


  • A Look at Locust Wood Capital's Top 3 Stocks

    Hedge fund Locust Wood Capital Advisers disclosed an equity portfolio valued at $723.56 million as of the end of the second quarter of 2015. The equity portfolio is mainly invested in consumer discretionary (33%), finance (25%), and health care (11%) stocks.

    The turnover ratio during the quarter was 35.71%. The fund made six new purchases and added to 14 existing stakes. On the other hand, it sold out nine stocks while reducing holdings in 19 stocks.


  • Steven Cohen Buys AerCap Holdings

    Point72 Asset Management L.P. is a family office managing the assets of its founder, Steven Cohen (Trades, Portfolio), and eligible employees. He is a billionaire hedge fund investor and the founder of SAC Capital Advisors. Cohen grew up in Great Neck, New York, and he attended the Wharton School of Business at the University of Pennsylvania.

    Last quarter, the firm initiated a position in AerCap Holdings NV (NYSE:AER), buying 665,200 shares. The following chart shows his holding history in the company.


  • Undervalued Stocks Among Steven Cohen's Recent Buys

    Steven Cohen (Trades, Portfolio) is the manager of Point72 Asset Management with a $14 billion portfolio that is composed of 712 stocks. According to GuruFocus' All-In-One screener, the following are the companies he recently bought with a wide margin of safety.

    During Q2 2015, he increased his stake by 2.86% in Potash Corp of Saskatchewan Inc (POT) and the company looks undervalued at the current price of $24.51. The DCF calculator gives a fair value of $46.05 with a current margin of safety of 47%. GuruFocus users confirm almost the same evaluation, giving to the company a fair value of $40.05, which was the average price after seven votes.


  • A Look at Steven Cohen's Investment in Ironwood Pharmaceuticals

    On Aug. 19, guru Steven Cohen (Trades, Portfolio), manager of Point72 Asset Management, bought shares of Ironwood Pharmaceuticals Inc. (IRWD) increasing his stake by 45.50% and reaching a total of 2,005,800 shares with a total loss of 9% since the first buy done in 2014Q3. The stake of IRWD represent the 0.16% of the guru’s total assets and 1.41% of outstanding shares of the company.

    The company


  • Billionaire Steven Cohen's New Oil Pick

    In this article, let's take a look at National Oilwell Varco, Inc. (NYSE:NOV), a $14.28 billion market cap company. The company designs and manufactures drill rig equipment, provides downhole tools and services and also provides supply chain integration services to the upstream oil and gas industry.

    New pick


  • Steven Cohen Buys Shares of Newly Offered Houlihan Lokey

    On Aug. 18 Steven Cohen (Trades, Portfolio) of Point72 Asset Management bought 569,640 shares of Houlihan Lokey (NYSE:HLI). The share buy in gives Point72 Asset Management a 5.4% stake in the company overall and a 0.1% position in Cohen’s portfolio with a value of $12.8 million.

    Cohen’s Point72 Asset Management was previously known as SAC Capital Advisors and Cohen has a strong track record of delivering above average returns for investors. Point72 Asset Management currently manages approximately $14.68 billion in equity assets utilizing a long-short equity strategy approach.


  • Valeant Pharmaceuticals' New Female Drug

    Valeant Pharmaceuticals (NYSE:VRX) has confirmed that it will pay $1.0 billion to buy Sprout Pharmaceuticals, the closely held company that has just won U.S. approval to sell the first drug that aims to increase women 's libido. Under the terms of the agreement, which echoes The Wall Street Journal, Valeant will pay $ 500 million in cash upfront and pay the other party early next year, whose pink pills, known as “female Viagra,” will be sold under the name Addyi. The deal is scheduled to close in the third quarter.

    Other acquisitions


  • Home Depot’s Earnings Beat Expectations and Show Accelerated Growth in Housing Market

    Home Depot (NYSE:HD) reported its second quarter 2015 earnings results on Aug. 18. The company reported revenue of $24.8 billion and earnings per share of $1.71. Revenue for the quarter beat analysts’ consensus estimate by $110 million and earnings per share were in line with consensus.

    Revenue for the quarter was up 4.2% from the year-ago quarter. Revenue for the first half of the year was also up 5.1% to $45.7 billion. Earnings of $2.2 billion increased 9% from the second quarter of 2014. Earnings per share also improved 14% from the comparable quarter. For the first half of the year, net earnings were up 11.2% to $3.8 billion and earnings per share increased 17.1%.


  • Three Stocks With Growing EPS Near 52-Week Lows - Part III

    With these articles, thanks to GuruFocus All-In-One Screener, I want to highlight stocks that have a strong price correction and are trading near their 52-week low. These stocks can be good for investors, since they reported growing earnings over the last few years.

    Yandex NV (YNDX)


  • Mondelez's EPS Decline on Sluggish Sales

    In this article, let's take a look at Mondelez International, Inc. (NASDAQ:MDLZ), a $73.48 billion market cap company, which is a global snack food company.

    Louis Moore Bacon (Trades, Portfolio) is an American hedge fund manager and trader who focuses on a global macro strategy to invest in the markets. This strategy focuses on indices, currencies, commodities and other asset classes based on expectations about specific markets and asset classes. They had their second consecutive month of net inflows in May. Although funds for $1.6 billion were added during the month, it was not enough to bring the flows to positive territory considering the entire year.


  • Steven Cohen Sells Portion of Stake in Olin Corporation

    Steven Cohen (Trades, Portfolio), founder and manager of SAC Capital Advisors, a Stamford, Connecticut based hedge fund, bought and sold stakes in Olin Corp (NYSE:OLN), a Missouri-based manufacturer of ammunition, chlorine and sodium hydroxide that was founded in 1892, regularly between 2010 and 2013. Between the middle of 2012 and the end of 2013, he bought new stakes in OLN twice and sold out three times, each time making a profit.

    He hadn’t traded in Olin stock since the end of 2013, but then in the first quarter of this year, he invested in a new stake in the company, acquiring 227,900 shares for an average price of $26.82 per share. That was nearly four times as many Olin shares as Cohen ever owned between 2010 and 2013, but then he made an astonishing addition at the end of June – buying 3,832,254 shares for an average price of $30.02 per share.


  • Context Capital Management's Top Sales in Q2 2015

    Context Capital Management, LLC filed in the last days its Q2 2015 and according to it, it ended the quarter with a portfolio value of $57.77 million (an increase of $2.59 million from the previous quarter. 48.42% of the institutional investor’s portfolio is listed in the US.

    During the quarter (Q2 2015) it bought 10 new stocks (here are listed the top 5 buys) and it sold out its stakes as follow :


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)